|
|
Yi Bai pharmaceutical 484 million purchase Changan
,tn requin pas cher
financial data show that in 2013, Changan international pharmaceutical achieved revenue of 100 million yuan, net profit of 36 million 10 thousand yuan; in 2014 1~5 months, to achieve revenue of 48 million 650 thousand yuan,chaussure tn pas cher, net profit of 16 million 550 thousand yuan. As of May 31, 2014, the total assets of the company amounted to $.
Changan international pharmaceutical main products for the third generation of platinum as the generation of platinum group,air max 95 pas cher, "national health insurance catalog" exclusive varieties. Yibai pharmaceutical, said the product and company core products in the field of tumor fit degree higher,tn requin femme pas cher, will further enhance the company's competitiveness in cancer drug market. After the completion of the acquisition, Changan international pharmaceutical products will be fully integrated into the company's sales resources, is conducive to the Changan international pharmaceutical core products bigger and stronger.
Changan international pharmaceutical subsidiary company
< p > on the same day, Yibai pharmaceutical released three of the Quarterly Bulletin, 2014 1-9 month, the company achieved revenues of 20.94 billion yuan,goyard paris, 19.08% year-on-year growth, net profit attributable to 3.08 billion yuan, up 21.39%; basic earnings per share of 0.786 yuan >
each intern reporter Yang Jian
< p > it is understood, Changan international pharmaceutical a total of 57 production licenses, 40 varieties, mainly divided into for anti tumor drugs,sac goyard pas cher, cardiovascular drugs,hogan sito ufficiale, anti infection medicine, antipyretic and analgesic drugs. Company's existing anti tumor drug substance,hogan outlet online, antitumor freeze dried powder injection and common injection, large capacity injection, solid dosage forms, such as seven national GMP production line.
< p > Yibai Pharmaceutical (600594, closing price of $37.29) October 31 announcement said the company intends to the price of a total of approximately 4.84 billion yuan,goyard pas cher, from the three companies acquisition Hainan Changan International Pharmaceutical Co.,tiffany co outlet, Ltd. (hereinafter referred to as Chang'an international pharmaceutical) 72.85% stake. After the completion of the acquisition, the company will be directly and indirectly holds 100% equity interest in Changan international pharmaceutical.
addition,tiffany outlet milano, a wholly owned subsidiary of Hainan brilliant technology holds 24.5% of Changan international pharmaceutical shares,scarpe hogan outlet, plus 2.65% of the shares held by the previous company. After the completion of the transaction, the company will hold 100% equity interest in Changan international pharmaceutical directly and indirectly.
"daily economic news" reporter noted that the Changan international pharmaceutical was in November 2010 ST long letter major asset restructuring when the loss of the sale of assets,air max femme pas cher, the book value of 0 yuan.
< p > announcement shows, Yibai pharmaceutical the acquisition consists of the following two parts: October 28, the company to 1.761 billion yuan transferee Guiyang hi tech holdings of Xi'an exquisite medicine 100% stake,woolrich outlet, which holds Changan international pharmaceutical 26.50% stake; October 29, the company and Hong Kong is express international investment and Guiyang hi tech innovation and technology investment signed equity transfer agreement,golden goose uomo, the two companies respectively held by the Changan international pharmaceutical 38.67% and 7.68% equity to 2.569 billion yuan and 5103 million transfer price to the company. The acquisition, the company accumulated a total cost of $yuan in direct and indirect way to acquire 72.85% stake in Changan international pharmaceutical.
Related topics:
Love in my heart
Shandong i
Xinlong electric (002298) the cost to market acceptance by each network
at present, Asahi able branch chairman and general manager named Yan Jun. It is also at this meeting of shareholders, Zhou Bin's wife Huang Wan was removed from the board of directors. |
|
楼主: 我不是春哥
[复制链接]
发表于 2016-1-8 23:04:01
发表于 2016-1-9 17:07:42
